CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

T.P. Rygiel; G. Karnam; G. Goverse; A.P. van der Marel; M.J. Greuter; R.A. van Schaarenburg; W.F. Visser; A.B. Brenkman; R. Molenaar; R.M. Hoek; R.E. Mebius; L. Meyaard

doi:10.1038/onc.2011.477

CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

T.P. Rygiel, G. Karnam, G. Goverse, A.P. van der Marel, M.J. Greuter, R.A. van Schaarenburg, W.F. Visser, A.B. Brenkman, R. Molenaar, R.M. Hoek, R.E. Mebius, L. Meyaard

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2979-2988
Number of pages	10
Journal	Oncogene
Volume	31
Issue number	24
DOIs	https://doi.org/10.1038/onc.2011.477
Publication status	Published - 2012

Access to Document

10.1038/onc.2011.477

http://www.nature.com/onc/journal/v31/n24/full/onc2011477a.html

Cite this

@article{640342c50b2344179d603e50c67418bb,

title = "CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.",

author = "T.P. Rygiel and G. Karnam and G. Goverse and {van der Marel}, A.P. and M.J. Greuter and {van Schaarenburg}, R.A. and W.F. Visser and A.B. Brenkman and R. Molenaar and R.M. Hoek and R.E. Mebius and L. Meyaard",

year = "2012",

doi = "10.1038/onc.2011.477",

language = "English",

volume = "31",

pages = "2979--2988",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "24",

}

TY - JOUR

T1 - CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

AU - Rygiel, T.P.

AU - Karnam, G.

AU - Goverse, G.

AU - van der Marel, A.P.

AU - Greuter, M.J.

AU - van Schaarenburg, R.A.

AU - Visser, W.F.

AU - Brenkman, A.B.

AU - Molenaar, R.

AU - Hoek, R.M.

AU - Mebius, R.E.

AU - Meyaard, L.

PY - 2012

Y1 - 2012

U2 - 10.1038/onc.2011.477

DO - 10.1038/onc.2011.477

M3 - Article

C2 - 22020332

SN - 0950-9232

VL - 31

SP - 2979

EP - 2988

JO - Oncogene

JF - Oncogene

IS - 24

ER -